Should We Listen to People Affected by Dementia?

CNS Neuroscience and Therapeutics

Volumn 17, Issue 1, 2011, Pages 1-3

  Rockwood, Kenneth ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CLINICAL PRACTICE; DEMENTIA; DISEASE COURSE; HUMAN; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; REVIEW; SOCIAL DISABILITY;

AGED; AGED, 80 AND OVER; DEMENTIA; GOALS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; RECOVERY OF FUNCTION;

EID: 78751500227     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00205.x     Document Type: Review

References (20)

1. Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New Engl J Med 1986;315:1241-1245.
2. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
3. Rockwood K, Fay S, Gorman M. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. Int J Geriatr Psychiatry 2010;25:191-201.
4. Rockwood K. Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:677-685.
5. Molnar FJ, Man-Son-Hing M, Fergusson D. Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc 2009;57:536-546.
6. Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Int Med 2008;148:379-397.
7. Raina P. Author reply. Ann Int Med 2008;149:359-360.
8. Rockwood K, Joffres C. Halifax consensus conference on understanding the effects of fementia treatment. Improving clinical descriptions to understand the effects of dementia treatment: Consensus recommendations. Int J Geriatr Psychiatry 2002;17:1006-1011.
9. Joffres C, Bucks RS, Haworth J, Wilcock GK, Rockwood K. Patterns of clinically detectable treatment effects with galantamine: A qualitative analysis. Dement Geriatr Cogn Disord. 2003;15:26-33.
10. Kiresuk TJ, Sherman RE. Goal attainment scaling: A general method for evaluating comprehensive community mental health programs Community Ment Health J 1968;4:443-453.
11. Rockwood K, Fay S, Song X, MacKnight C, Gorman M. Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: A randomized controlled trial. CMAJ 2006;174:1099-1105.
12. Cook C, Fay S, Rockwood K. Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: A descriptive analysis from the VISTA clinical trial. Int Psychogeriatr 2008;20:952-963.
13. Royall DR, Lauterbach EC, Cummings JL, et al. Executive control function: A review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002;14:377-405.
14. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci 2003;23:986-993.
15. Behl P, Lanctôt KL, Streiner DL, Black SE. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: A two-year observational study in the Sunnybrook dementia cohort. Int Psychogeriatr 2008;20:1141-1159.
16. Bullock R, Lane R. Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase. Curr Alzheimer Res 2007;4:277-293.
17. Folstein MF, Folstein S, McHugh PR. Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Rockwood K. An individualized approach to tracking and treating Alzheimer's disease. Clin Pharmacol Ther 2010;88:446-449
19. Rockwood, K, Li, Y, Fay S, Mitnitski A. Patient/care partner goals of dementia treatment: Comparing clinical trial and web-based accounts. Alz Dem 2008;4(2 Suppl):T174.
20. Rockwood K, Fay S, Jarrett P, Asp E. Effect of galantamine on verbal repetition in AD: A secondary analysis of the VISTA trial. Neurology 2007;68:1116-1121.